The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181, 7176-7185
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naiki, Y.
Right arrow Articles by Arditi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naiki, Y.
Right arrow Articles by Arditi, M.

TLR/MyD88 and Liver X Receptor {alpha} Signaling Pathways Reciprocally Control Chlamydia pneumoniae-Induced Acceleration of Atherosclerosis1

Yoshikazu Naiki*,#, Rosalinda Sorrentino, Michelle H. Wong*, Kathrin S. Michelsen*, Kenichi Shimada*, Shuang Chen*, Atilla Yilmaz{dagger}, Anatoly Slepenkin{ddagger}, Nicolas W. J. Schröder*, Timothy R. Crother*, Yonca Bulut*, Terence M. Doherty*, Michelle Bradley§, Zory Shaposhnik, Ellena M. Peterson{ddagger}, Peter Tontonoz§, Prediman K. Shah|| and Moshe Arditi2,*

* Division of Pediatric Infectious Diseases, Cedars-Sinai Medical Center and David Geffen School of Medicine, University of California, Los Angeles, CA 90048; {dagger} Medical Clinic II, University of Erlangen-Nuremburg, Erlangen, Germany; {ddagger} Department of Pathology, University of California, Irvine, California 92697; § Molecular Biology Institute and Division of Cardiology, University of California, Los Angeles, CA, 90095; || Division of Cardiology and Oppenheimer Atherosclerosis Research Center, Cedars-Sinai Medical Center and the University of California, Los Angeles, CA 90048; and # Department of Microbiology and Immunology, Aichi Medical University, Nagakute, Japan

Experimental and clinical studies link Chlamydia pneumoniae infection to atherogenesis and atherothrombotic events, but the underlying mechanisms are unclear. We tested the hypothesis that C. pneumoniae-induced acceleration of atherosclerosis in apolipoprotein E (ApoE)–/– mice is reciprocally modulated by activation of TLR-mediated innate immune and liver X receptor {alpha} (LXR{alpha}) signaling pathways. We infected ApoE–/– mice and ApoE–/– mice that also lacked TLR2, TLR4, MyD88, or LXR{alpha} intranasally with C. pneumoniae followed by feeding of a high fat diet for 4 mo. Mock-infected littermates served as controls. Atherosclerosis was assessed in aortic sinuses and in en face preparation of whole aorta. The numbers of activated dendritic cells (DCs) within plaques and the serum levels of cholesterol and proinflammatory cytokines were also measured. C. pneumoniae infection markedly accelerated atherosclerosis in ApoE-deficient mice that was associated with increased numbers of activated DCs in aortic sinus plaques and higher circulating levels of MCP-1, IL-12p40, IL-6, and TNF-{alpha}. In contrast, C. pneumoniae infection had only a minimal effect on atherosclerosis, accumulation of activated DCs in the sinus plaques, or circulating cytokine increases in ApoE–/– mice that were also deficient in TLR2, TLR4, or MyD88. However, C. pneumoniae-induced acceleration of atherosclerosis in ApoE–/– mice was further enhanced in ApoE–/–LXR{alpha}–/– double knockout mice and was accompanied by higher serum levels of IL-6 and TNF-{alpha}. We conclude that C. pneumoniae infection accelerates atherosclerosis in hypercholesterolemic mice predominantly through a TLR/MyD88-dependent mechanism and that LXR{alpha} appears to reciprocally modulate and reduce the proatherogenic effects of C. pneumoniae infection.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the National Institute of Allergy and Infectious Diseases and the National Heart, Lung, and Blood Institute (NHLBI) (5R01AI058128, 5R01AI067995, and RO1HL66436 to M.A.) and the NHLBI (2P01HL030568 and 5R01HL066088 to P.T.). P.T. is an investigator of the Howard Hughes Medical Institute. A. Y. is funded by the German Heart Foundation.

2 Address correspondence and reprint requests to Dr. Moshe Arditi, Cedars Sinai Medical Center, Division of Pediatric Infectious Diseases and Immunology, 8700 Beverly Boulevard, Room 4221, Los Angeles, CA 90048. E-mail address: moshe.arditi{at}cshs.org

3 Abbreviations used in this paper: LXR, liver X receptor; ApoE, apolipoprotein E; DC, dendritic cell; EC, endothelial cell; IFU, inclusion-forming unit; MOI, multiplicity of infection; ox-LDL, oxidized low-density lipoprotein.




This article has been cited by other articles:


Home page
Circ. Res.Home page
A. Yilmaz and M. Arditi
Giant Cell Arteritis: Dendritic Cells Take Two T's to Tango
Circ. Res., February 27, 2009; 104(4): 425 - 427.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.